Skip to main content
BVS logo
BVS
(NASDAQ)
Bioventus Inc.
$9.73-- (--)
Loading... - Market loading

Bioventus (BVS) Stock Price & Financial Analysis

Bioventus Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.46 - $9.77
52-Week High$11.25
52-Week Low$5.81
Open$9.48
Volume593.22K
Average Volume (3M)663.22K
Market Cap665.08M
Shares Outstanding70.01M
P/E Ratio (TTM)23.35
Price to Sales (P/S)1.15
Price to Book (P/B)3.52
EV/EBITDA8.73
Revenue (TTM)576.30M
Net Income (TTM)28.48M
Free Cash Flow (TTM)100.63M
EPS (TTM)$0.41
Profit Margin4.94%
Operating Margin10.60%
Return on Equity (ROE)15.08%
Debt to Equity1.44
50-Day MA$9.61
200-Day MA$8.22
52-Week Change40.53%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Bioventus

What is the current stock price for BVS?

As of the latest trading session, BVS stock trades at $9.73. The 52-week range is $5.81–$11.25, with a day range of $9.46–$9.77.

What is the P/E ratio for BVS?

Bioventus's trailing P/E ratio is 23.4, meaning investors pay $23.4 for every $1 of annual earnings. Bioventus operates in the Healthcare sector.

Does BVS pay dividends?

Bioventus does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BVS?

Based on 1 analyst, the consensus for BVS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BVS?

Bioventus's market capitalization is $681.2M, classifying it as a small-cap company. Bioventus operates in the Healthcare sector within the Medical Devices industry.